Addiction News

Less than 7% of individuals with mental health or substance use disorders receive effective treatment worldwide, according to a cross-sectional analysis published in JAMA Psychiatry.

The incidence of cannabis use disorder associated with schizophrenia almost tripled among Canadian teenagers and adults after cannabis legalization, according to a study published in JAMA Network Open.

Although the prevalence of substance use disorder increased during the COVID-19 pandemic, the receipt of treatment declined before rebounding, according to a research letter published in JAMA Network Open.

The adjusted risk for COPD was elevated among adults who identified as regular cigarette smokers before age 15 years, according to results published in Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation.

Candidate genetic variants included in a genetic risk algorithm may not meet standards of reasonable clinical efficacy in identifying opioid use disorder risk, according to a study published in JAMA Network Open.

An online-based mindfulness treatment program significantly reduced opioid craving among participants with opioid use disorder results from a randomized clinical trial published in JAMA Network Open showed.

Low-dose initiation of buprenorphine in an outpatient setting showed low rates of success among a cohort of adults with opioid use disorder who self-reported daily fentanyl use, according to a study published in JAMA Network Open.

Adults aged 18 to 49 years who used cannabis for medical reasons had higher rates of cannabis use disorder compared with adults who only used cannabis recreationally, according to a research letter published in JAMA Psychiatry.

The volume of those who received medications for opioid use disorder at federally qualified health centers more than doubled over a recent 6-year span, results from a cross-sectional study showed.